Showing results (211-220 of 563) with videos related to
Sort By:
Pageof 57
The Journal of Family Practice|January 1, 1988
Impact of an HMO on a university-based family practice programP Curtis, S Sloat, J Aluise, et al.Maternal and Child Health Journal|August 18, 2016
Reassessing the Association between WIC and Birth Outcomes Using a Fetuses-at-Risk ApproachKathryn R Fingar, Sibylle H Lob, Melanie S Dove, et al.British Journal of Rheumatology|December 24, 1997
Pachydermoperiostosis in childhoodG P Sinha, P Curtis, D Haigh, et al.Alimentary Pharmacology & Therapeutics|July 15, 2009
Prescription rates of protective co-therapy for NSAID users at high GI risk and results of attempts to improve adherence to guidelinesL Laine, L Connors, M R Griffin, et al.Archives of Drug Information|February 17, 2010
A Comparison of Cardiovascular Biomarkers in Patients Treated for Three Months with Etoricoxib, Celecoxib, Ibuprofen, and PlaceboChristopher P Cannon, Cong Chen, Sean P Curtis, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 21, 2002
A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patientsJ Hardy, S Daly, B McQuade, et al.Journal of Cardiac Failure|October 10, 2021
Trends in ICD Implantations and in-Hospital Outcomes After DOJ InvestigationPaul M Bourdillon, Craig S Parzynski, Karl E Minges, et al.Circulation|November 7, 2013
Temporal trends in quality of care among recipients of implantable cardioverter-defibrillators: insights from the National Cardiovascular Data RegistryJohn A Dodson, Rachel Lampert, Yongfei Wang, et al.JAMA|February 8, 1995
National assessment of physicians' breast-feeding knowledge, attitudes, training, and experienceG L Freed, S J Clark, J Sorenson, et al.Current Medical Research and Opinion|February 3, 2007
Pooled analysis of thrombotic cardiovascular events in clinical trials of the COX-2 selective Inhibitor etoricoxibSean P Curtis, Amy T Ko, James A Bolognese, et al.Pageof 57